Viveon Health Acquisition 's Cash & cash equivalent grew by 292.31 % in the Q1 2023 sequentially, while Current Liabilities decreased, this led to improvement in Viveon Health Acquisition 's Quick Ratio to 0.01, Quick Ratio remained below Viveon Health Acquisition Corp average.

Within Major Pharmaceutical Preparations industry 628 other companies have achieved higher Quick Ratio than Viveon Health Acquisition in first quarter 2023. While Quick Ratio total ranking in the first quarter 2023 has deteriorated compared to the prior quarter from 5778 to 5800.

Explain Quick Ratio?
How much Cash & cash equivalents VHAQ�s has?
What are VHAQ�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/VHAQ/financial-strength

https://api.csimarket.com/api/v1/companies/VHAQ/fundamentals

https://api.csimarket.com/api/v1/companies/VHAQ/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

VHAQ Quick Ratio	(Mar 31 2023) Q1	(Dec 31 2022) Q4	(Sep 30 2022) Q3	(Jun 30 2022) Q2	(Mar 31 2022) Q1
Y / Y Current Liabilities Change	-23.11 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-96.26 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.01	Subscribe	Subscribe	Subscribe	Subscribe
VHAQ's Total Ranking	# 5800	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-80.89 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	292.31 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio first quarter 2023 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 629
Healthcare Sector	# 1242
Overall Market	# 5800

Quick Ratio Statistics
High	Average	Low
500	45.56	0
(Sep 30 2020)		(Dec 31 2022)

Financial Statements
Viveon Health Acquisition 's Current Liabilities	$ 8 Millions	Visit VHAQ's Balance sheet
Viveon Health Acquisition 's Cash & cash equivalent	$ 0 Millions	Visit VHAQ's Balance sheet
Source of VHAQ's Sales		Visit VHAQ's Sales by Geography

Cumulative Viveon Health Acquisition 's Quick Ratio

VHAQ's Quick Ratio for the trailling 12 Months

VHAQ Quick Ratio	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months	(Sep 30 2022) 12 Months	(Jun 30 2022) 12 Months	(Mar 31 2022) 12 Months
Y / Y Current Liabilities TTM Growth	144.23 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-55.05 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.03	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4668	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-3.32 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-52.02 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to VHAQ Financial Strength Comparisons >> Go to Compare VHAQ Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in VHAQ's Current Liabilities to $7.84 millions, cumulative Quick Ratio to 0.03 below the VHAQ average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 600 other companies have achieved higher Quick Ratio than Viveon Health Acquisition . While Quick Ratio overall ranking has improved so far to 4668, from total ranking during the twelve months ending fourth quarter 2022 at 4922.

Explain Quick Ratio?
How much Cash & cash equivalents VHAQ�s has?
What are VHAQ�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 601
Healthcare Sector	# 1195
Within the Market	# 4668

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.33	0.15	0.03
(Dec 31 2021)

Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Major Pharmaceutical Preparations Industry	Quick Ratio	Mar 31 2023 MRQ Cash & cash equivalent	Mar 31 2023 MRQ Current Liabilities
Allarity Therapeutics Inc	0.03	$ 0.295 Millions	$ 11.588 Millions
Cnbx Pharmaceuticals Inc	0.02	$ 0.048 Millions	$ 2.250 Millions
Ocean Biomedical Inc	0.02	$ 0.306 Millions	$ 17.178 Millions
Regen Biopharma Inc	0.02	$ 0.088 Millions	$ 5.336 Millions
Biostax Corp	0.01	$ 0.048 Millions	$ 3.576 Millions
Serina Therapeutics Inc	0.01	$ 0.280 Millions	$ 21.448 Millions
Axim Biotechnologies Inc	0.01	$ 0.059 Millions	$ 4.863 Millions
Oncotelic Therapeutics Inc	0.01	$ 0.190 Millions	$ 17.597 Millions
Skinvisible Inc	0.01	$ 0.029 Millions	$ 2.726 Millions
Viveon Health Acquisition Corp	0.01	$ 0.078 Millions	$ 7.841 Millions
Intellipharmaceutics International Inc	0.01	$ 0.070 Millions	$ 7.280 Millions
Evofem Biosciences Inc	0.01	$ 0.639 Millions	$ 79.808 Millions
Sangui Biotech International Inc	0.01	$ 0.007 Millions	$ 1.027 Millions
Theralink Technologies Inc	0.00	$ 0.228 Millions	$ 53.422 Millions
Provectus Biopharmaceuticals Inc	0.00	$ 0.034 Millions	$ 8.660 Millions
Rapid Therapeutic Science Laboratories Inc	0.00	$ 0.018 Millions	$ 4.463 Millions
Novaccess Global Inc	0.00	$ 0.022 Millions	$ 5.830 Millions
Kaya Holdings Inc	0.00	$ 0.030 Millions	$ 9.690 Millions
Adhera Therapeutics Inc	0.00	$ 0.069 Millions	$ 23.197 Millions
Q Biomed inc	0.00	$ 0.023 Millions	$ 9.906 Millions
REGENEREX PHARMA, INC.	0.00	$ 0.001 Millions	$ 0.519 Millions

Date modified: 2026-09-08T15:11:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.